7月24日 - ** 医疗设备制造商West Pharmaceutical Services WST.N股价盘前上涨12.9%，至256.5美元
** 公司预计年度利润在每股6.65美元到6.85美元之间，而之前的区间为每股6.15美元到6.35美元
** 预计全年销售额在 30.4 亿美元至 30.6 亿美元之间，此前预计为 29.5 亿美元至 29.8 亿美元
** 公司公布的第二季度每股收益为1.84美元，高于分析师预计的每股收益1.51美元--数据由LSEG编制
** 第二季度销售额为 7.665 亿美元，分析师预计为 7.275 亿美元。
** 截至收盘，股价累计下跌 30.6
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.